GENELUX CORP

Profile

Company Names

GENELUX CORP

Addresses

2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA 91361

1177 IDAHO STREET, SUITE 202, REDLANDS, CA 92374

3030 BUNKER HILL STREET, SUITE 310, SAN DIEGO, CA 92109

1615 ORANGE TREE LANE, SUITE 203, REDLANDS, CA 92374

Phone Numbers

805-267-9889
858-483-0024
909-307-9300

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

CA

Total Amount Raised:

$24,413,587.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2023-06-20 
$5,500,000.00 
$18,000,000.00 
$12,500,000.00 
Equity 
4
2023-05-31 
$18,304,319.00 
$33,304,319.00 
$15,000,000.00 
Equity 
3
2012-04-24 
$481,268.00 
$48,000,000.00 
$47,518,732.00 
Equity 
2
2010-06-24 
$80,000.00 
$25,000,000.00 
$24,920,000.00 
Equity 
1
2009-03-17 
$48,000.00 
$25,000,000.00 
$24,952,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOACHIM-FRIEDRICH 
 
KAPP 
DIRECTOR
MARY 
 
MIRABELLI 
DIRECTOR
ALBERT 
H. 
RODER 
DIRECTOR, EXECUTIVE OFFICER
ALBERT 
H. 
ROEDER 
EXECUTIVE OFFICER, DIRECTOR
DOUG 
 
SAMUELSON 
EXECUTIVE OFFICER
PAUL 
 
SCIGALLA 
EXECUTIVE OFFICER
RONALD 
R. 
SIMUS 
EXECUTIVE OFFICER, DIRECTOR
CAROLINE 
 
STAIB 
EXECUTIVE OFFICER
ALADAR 
A. 
SZALAY 
DIRECTOR, EXECUTIVE OFFICER
GABE 
 
WOODWARD 
DIRECTOR
THOMAS 
 
ZINDRICK 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-06-20 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-05-31 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2012-04-24 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2010-06-24 
D
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-03-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#